Background: Type 2 Diabetes Mellitus (T2DM) is a significant public health challenge worldwide. Abelmoschus esculentus (okra) contains soluble fibers, polysaccharides, and antioxidants that may help regulate blood glucose. This study evaluated the effectiveness of okra water in improving glycaemic control and symptom burden among hospitalized T2DM patients. Methods: A quasi-experimental one-group pretest–posttest design was conducted among 95 hospitalized T2DM patients aged 25–70 years in Tumkur, India. Participants consumed 200 mL of water infused overnight with three medium-sized okra pods each morning for 15 consecutive days. Fasting blood sugar (FBS), 1.5-hour postprandial blood sugar (PPBS), and Diabetes Impact Measurement Scale (DIMS) scores were assessed pre- and post-intervention. Paired t-tests were used for statistical analysis, with significance set at p < 0.05. Results: Mean FBS decreased from 165.3 ± 28.7 mg/dL to 148.7 ± 24.2 mg/dL (t = 7.12, p < 0.001), and PPBS from 198.6 ± 36.5 mg/dL to 175.9 ± 31.1 mg/dL (t = 8.05, p < 0.001). DIMS scores improved from 3.42 ± 0.34 to 3.18 ± 0.29 (t = 6.01, p < 0.001). Conclusion: Daily consumption of okra water significantly improved short-term glycaemic control and reduced symptom burden in hospitalized T2DM patients. It may serve as a safe, low-cost adjunct to conventional therapy, though longer-term randomized trials are recommended.
